HeartSciences (HSCSW) Change in Receivables (2022 - 2025)
HeartSciences' (HSCSW) quarterly Change in Receivables came in at -$4350.0 in Q3 2025, down 200.0% quarter-over-quarter from $4350.0 in Q2 2025.
Analysis
HeartSciences (HSCSW) Change in Receivables (2022 - 2025) Analysis & Trends
HeartSciences (HSCSW) has reported Change in Receivables for 3 consecutive years, with -$4350.0 the latest figure, recorded in Q3 2025.
- For the quarter ending Q3 2025, Change in Receivables changed N/A year-over-year to -$4350.0; the trailing twelve-month figure through Oct 2025 stood at $10800.0 (changed N/A YoY), and the FY2026 full-year result was -$4350.0, down 200.0% from the prior year.
- Change in Receivables fell to -$4350.0 in Q3 2025 per HSCSW's latest filing, from $4350.0 in the prior quarter.
- Across five years, Change in Receivables topped out at $10800.0 in Q1 2024 and bottomed at -$4350.0 in Q3 2025.
- Historically, Change in Receivables has averaged $2119.8 across 3 years, with a median of $1014.5 in 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 29.78 Bn | 27.67 Bn | 2.18 Bn | 79.00 Mn |
| 2 | Lantheus Holdings | 6.58 Bn | 5.99 Bn | 241.86 Mn | -3.28 Mn |
| 3 | Heartflow | 4.11 Bn | 3.74 Bn | 53.19 Mn | - |
| 4 | Neogen | 2.60 Bn | 2.41 Bn | 107.80 Mn | 9.80 Mn |
| 5 | Butterfly Network | 1.99 Bn | 1.86 Bn | 23.29 Mn | 10.05 Mn |
| 6 | Ceribell | 921.90 Mn | 792.63 Mn | 25.94 Mn | 283,000.00 |
| 7 | QuidelOrtho | 886.88 Mn | 763.48 Mn | - | -8.90 Mn |
| 8 | Varex Imaging | 779.06 Mn | 679.86 Mn | 76.70 Mn | -3.20 Mn |
| 9 | Prenetics Global | 338.37 Mn | 279.32 Mn | 30.20 Mn | -2.60 Mn |
| 10 | HeartSciences | 184,567.09 | -1.52 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jul 31, 2025 | -4,350.00 |
| Apr 30, 2025 | 4,350.00 |
| Jan 31, 2024 | 10,800.00 |
| Jul 31, 2022 | -2,321.00 |